CoreCivic, Inc. filings document the public-company record for a Maryland corporation with common stock listed on the New York Stock Exchange under CXW. Form 8-K disclosures report quarterly financial results and guidance, material credit agreement amendments, revolving credit and term loan arrangements, share repurchase authorization, and executive appointments.
Proxy materials cover annual meeting voting matters, board governance, compensation and shareholder procedures. The filing record also documents securities registration details, capital structure actions, and formal exhibits such as earnings releases and credit facility amendments tied to the company’s corrections, detention, reentry and government real estate operations.
CoreCivic, Inc. Schedule 13G/A (Amendment No. 4) reports that Cooper Creek Partners Management LLC, via John McCleary, beneficially owns 2,849,459 shares of CoreCivic common stock (CUSIP 21871N101), representing 2.7% of the class. The filing is signed by John McCleary as CFO on 05/15/2026.
Emkes Mark A reported acquisition or exercise transactions in this Form 4 filing.
CoreCivic, Inc. director Mark A. Emkes received an equity award in the form of restricted stock units. He was granted 2,824 RSUs on the grant date, each representing one share of common stock, at a reference price of $21.25 per share. These RSUs vest in full on the first anniversary of the grant date, as long as he continues serving with the company through that vesting date. Following this award, he holds 171,274 shares of common stock directly, so the grant represents a relatively small addition to his existing stake.
CoreCivic reported strong Q1 2026 results, with revenue rising to $614.7 million and net income increasing to $37.9 million, or $0.38 per diluted share. Growth was driven mainly by higher federal revenue from U.S. Immigration and Customs Enforcement, as new and reactivated ICE contracts boosted average occupancy and per‑diem rates. Operating costs also climbed with wage increases, staffing for added capacity, and startup expenses at several facilities, though employee retention credits partially offset these pressures. Cash rose to $209.7 million while total debt expanded to $1.41 billion as the company funded share repurchases and capacity growth.
CoreCivic reported a strong first quarter of 2026, boosted by facility activations and higher federal and state populations. Total revenue rose to $614.7 million, up 25.8% from a year earlier. Net income increased to $37.9 million, or $0.38 per diluted share, with Adjusted Diluted EPS at $0.40.
Profitability improved, with Adjusted EBITDA reaching $110.1 million, up 36.0%, and Normalized FFO per diluted share rising to $0.65. The company repurchased 2.3 million shares for $44.7 million, and leverage stood at 2.8x net debt to Adjusted EBITDA.
CoreCivic completed a roughly $148.0 million acquisition of Clinical Solutions Pharmacy, expects it to add $0.03–$0.05 per share in 2026, and raised full-year 2026 guidance for net income, EPS, FFO and Adjusted EBITDA. Updated guidance incorporates the CSP acquisition and the Midwest Regional Reception Center activation, while acknowledging a recent decrease in nationwide ICE populations.
CoreCivic, Inc. Amendment No. 3 to a Schedule 13G/A: River Road Asset Management, LLC reports beneficial ownership of 9,011,396 shares of Common Stock, representing 9.1% of the class. The filer reports sole voting power for 7,758,282 shares and sole dispositive power for 9,011,396 shares. The filing is signed on 05/05/2026 and shows a date of 03/31/2026 on the cover.
CoreCivic, Inc. Chief Administrative Officer Cole G. Carter executed an open-market sale of 12,500 shares of common stock at $20.64 per share. The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan, and Carter continues to directly hold 228,383 shares after the sale.
CXW submitted a Rule 144 notice reporting proposed and completed transactions in Common Stock. The filing records an RSU vesting event of 73,348 shares on 03/06/2025 and two reported dispositions by Cole G Carter: 12,500 shares sold on 03/02/2026 for $219,750.00 and 12,500 shares sold on 04/01/2026 for $236,212.00. Other header figures shown include 12500, $254,875.00, and 98,890,000 with an as of date 05/01/2026.
CoreCivic Inc reported that Vanguard Capital Management beneficially owns 5,002,380 shares of Common Stock, representing 5.11% of the class. The filing states Vanguard has sole dispositive power over 5,002,380 shares and sole voting power for 750,286 shares. The filing notes these holdings include positions held for Vanguard funds and certain affiliated investment vehicles.
CoreCivic Inc reported that Vanguard Portfolio Management beneficially owns 6,999,033 shares of Common Stock, representing 7.16% of the class. The filing shows Vanguard has sole dispositive power over 6,999,033 shares and sole voting power for 47,427 shares.
The disclosure is filed on behalf of Vanguard Portfolio Management and affiliated Vanguard entities and is signed by Ashley Grim, Head of Global Fund Administration.
CoreCivic, Inc. entered into a Second Amendment to its Fourth Amended and Restated Credit Agreement, adding a new $100 million Incremental Term Loan to its existing credit facility. The company plans to use this borrowing to pay down part of its revolving credit facility and for working capital and general corporate purposes.
Following the amendment, the total Amended Credit Facility is $800 million, consisting of a $125 million initial term loan, the new $100 million Incremental Term Loan, and a $575 million revolving credit facility with sublimits for swingline loans and standby letters of credit. The Incremental Term Loan matures 364 days after the amendment date and carries an interest margin 25 basis points higher than the margin on the initial term loan and revolver, which varies with CoreCivic’s consolidated total leverage ratio.